Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VADADUSTAT for Nephrogenic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 140 adverse event reports in the FDA FAERS database where VADADUSTAT was used for Nephrogenic anaemia.

Most Reported Side Effects for VADADUSTAT

Side Effect Reports % Deaths Hosp.
Death 14 8.0% 14 2
Marasmus 12 6.9% 12 1
Cardiac failure 10 5.7% 8 3
Pneumonia 9 5.1% 6 4
Cardiac failure congestive 8 4.6% 3 7
Diarrhoea 8 4.6% 1 4
Pneumonia aspiration 8 4.6% 8 1
Cerebral infarction 7 4.0% 2 5
Haemoglobin decreased 7 4.0% 1 0
Nausea 7 4.0% 2 1
End stage renal disease 6 3.4% 1 1
Off label use 6 3.4% 0 3
Cardiac failure chronic 5 2.9% 4 1
Chronic kidney disease 5 2.9% 5 0
Decreased appetite 5 2.9% 1 5

Other Indications for VADADUSTAT

Product used for unknown indication (27) Chronic kidney disease (5)

Other Drugs Used for Nephrogenic anaemia

DARBEPOETIN ALFA (5,332) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331) ARANESP (1,740) DAPRODUSTAT (859) ERYTHROPOIETIN (750) PEGZEREPOETIN ALFA (325) EPOETIN ALFA-EPBX (169) MIRCERA (100) ENARODUSTAT (66) ROXADUSTAT (57)

Related Pages

VADADUSTAT Full Profile All Nephrogenic anaemia Drugs VADADUSTAT Demographics VADADUSTAT Timeline